|
|
|
Volumn 54, Issue 7, 1999, Pages 583-587
|
|
Treatment of combined hyperlipidaemia: Fibrate or/and statin?;Traitement de l'hyperlipidemie combinee: Fibrate ou/et statine?
a
|
|
Author keywords
Cardiovascular risk; Cholesterol; Combined hyperlipidaemia; Fibrates; Statins; Triglycerides
|
|
Indexed keywords
ATORVASTATIN;
BEZAFIBRATE;
CERIVASTATIN;
CHOLESTEROL;
CIPROFIBRATE;
CLOFIBRATE;
FENOFIBRATE;
FIBRIC ACID DERIVATIVE;
FLUINDOSTATIN;
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN;
PRAVASTATIN;
SIMVASTATIN;
TRIACYLGLYCEROL;
VERY LOW DENSITY LIPOPROTEIN;
HYPOCHOLESTEROLEMIC AGENT;
ALCOHOL CONSUMPTION;
ARTICLE;
CARDIOVASCULAR RISK;
DRUG CHOICE;
DRUG CONTRAINDICATION;
HIGH RISK PATIENT;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
HYPERTRIGLYCERIDEMIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PREVALENCE;
RHABDOMYOLYSIS;
RISK FACTOR;
CARDIOVASCULAR DISEASE;
DECISION MAKING;
ANTICHOLESTEREMIC AGENTS;
CARDIOVASCULAR DISEASES;
DECISION MAKING;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
HYPERTRIGLYCERIDEMIA;
RISK FACTORS;
|
|
EID: 0033163194
PISSN: 00353663
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (42)
|
